Effects of the Oral Oxytocin Receptor Antagonist Tocolytic OBE001 on Reproduction in Rats.

about

Effects of the Oral Oxytocin Receptor Antagonist Tocolytic OBE001 on Reproduction in Rats.

Item

http://www.wikidata.org/entity/Q50980255

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Effects of the Oral Oxytocin R ...... BE001 on Reproduction in Rats.

@en

Effects of the Oral Oxytocin R ...... BE001 on Reproduction in Rats.

@nl

type

Item

label

Effects of the Oral Oxytocin R ...... BE001 on Reproduction in Rats.

@en

Effects of the Oral Oxytocin R ...... BE001 on Reproduction in Rats.

@nl

prefLabel

Effects of the Oral Oxytocin R ...... BE001 on Reproduction in Rats.

@en

Effects of the Oral Oxytocin R ...... BE001 on Reproduction in Rats.

@nl

P1476

Effects of the Oral Oxytocin R ...... BE001 on Reproduction in Rats.

@en

P2093

André Chollet

http://www.w3.org/2001/XMLSchema#string

Deborah Perks

http://www.w3.org/2001/XMLSchema#string

Jon Rhodes

http://www.w3.org/2001/XMLSchema#string

Laura Comotto

http://www.w3.org/2001/XMLSchema#string

Oliver Pohl

http://www.w3.org/2001/XMLSchema#string

Paul Baldrick

http://www.w3.org/2001/XMLSchema#string

P2860

Oxytocin antagonists: clinical and scientific considerations.

The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents.

Increased risk of preterm birth in singleton pregnancies resulting from in vitro fertilization-embryo transfer or gamete intrafallopian transfer: a meta-analysis.

Born too soon: preterm birth matters.

Pre- and postnatal developmental toxicity study design for pharmaceuticals.

Uterine contractions at the time of embryo transfer alter pregnancy rates after in-vitro fertilization.

Toxicity profile of solvents by aspiration approach for topical agent delivery to respiratory tract epithelium.

Treatment with oxytocin antagonists before embryo transfer may increase implantation rates after IVF.

Assessment of Labrasol/Labrafil/Transcutol (4/4/2, v/v/v) as a non-clinical vehicle for poorly water-soluble compounds after 4-week oral toxicity study in Wistar rats.

Pharmacology of (2S,4Z)-N-[(2S)-2-hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a new potent and selective nonpeptide antagonist of the oxytocin receptor.

P304

439-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1933719115607979

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26399985

http://www.w3.org/2001/XMLSchema#string

P921

oxytocin